Search: C 45

Ayr Strategies Reports Third Quarter 2020 Results & Updates Investors on 2021 Expansion Initiatives Q3 Revenue up 61% Q/Q to $45.5 Million; Adjusted EBITDA More Than Doubles to $19.3 Million Annual Revenue & Adjusted EBITDA Run-Rate of $182 Million and $77 Million, Respectively Generated Over $13 Million in Cash from Operations in Q3; Cash Balance […] READ MORE: https://www.newcannabisventures.com/ayr-strategies-q3-revenue-increases-61-sequentially-to-45-5-million/

Statistics Canada released August retail sales for the country this morning, with sequential growth slowing from last month’s 15% gain, as overall cannabis sales grew 6% sequentially to C$244.9 million, up 94% from a year ago. The report detailed how Ontario, which grew 11% to C$66.9 million, drove the sales, as other major provinces increased 2-5%: August’s […] READ MORE: https://www.newcannabisventures.com/ontario-drives-canadian-cannabis-sales-6-higher-in-august-to-245-million/

Trulieve Announces Underwritten Offering of Subordinate Voting Shares TALLAHASSEE, Fla., Sept. 16, 2020 /CNW/ – Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States, today announced that it has entered into an agreement with Canaccord Genuity Corp. (the “Underwriter”), pursuant to which the […] READ MORE: https://www.newcannabisventures.com/trulieve-raises-c100-45-million-selling-shares-at-c24-50/

The Valens Company Reports Financial Results for the Second Quarter of Fiscal 2020 KELOWNA, BC, July 15, 2020 /PRNewswire/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to report its second quarter financial […] READ MORE: https://www.newcannabisventures.com/valens-q2-revenue-drops-45-sequentially-to-17-6-million/

MedMen Reports Third Quarter Fiscal 2020 Financial Results – Designated News Release Third quarter revenue of $45.9 million, up 41% year over year Corporate SG&A decreased by 35% sequentially and 51% from the prior year period Strengthened balance sheet through combination of equity, debt and sale of non-core assets Achieved first month of positive after-tax […] READ MORE: https://www.newcannabisventures.com/medmen-revenue-increases-4-sequentially-in-q3-to-45-9-million/

Harvest Health & Recreation Inc. Reports First Quarter 2020 Financial Results First quarter revenue was $45.0 million, up 134% from the first quarter 2019 and 19% sequentially Cost cutting measures expected to save $24 million annually PHOENIX, May 20, 2020 /PRNewswire/ — Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis […] READ MORE: https://www.newcannabisventures.com/harvest-health-generates-45-million-revenue-in-q1-and-projects-200-million-for-the-full-year/

Cronos Group Reports 2020 First Quarter Results Fermented target cannabinoid, CBGA, using cannabinoid strains at Cronos Fermentation R&D labs Successfully completed first dried flower shipment to Israel, as Cronos Israel moves closer to entering the medical cannabis market with PEACE NATURALS™ branded products Natuera completes key operational milestones and begins test exports to the U.S. […] READ MORE: https://www.newcannabisventures.com/cronos-group-underwhelms-again-with-just-8-4-million-revenue-and-a-45-1-million-operating-loss-in-q1/

Constellation Brands Exercises Warrants to Acquire Shares in Canopy Growth, Reinforcing Confidence in Canopy Growth’s Ability to Win Long-Term in Emerging Cannabis Industry VICTOR, NY and SMITHS FALLS, ON, May 1, 2020 /PRNewswire/ – Constellation Brands, Inc. (“Constellation Brands”) (NYSE: STZ) and (NYSE: STZ.B), a leading beverage alcohol company, and Canopy Growth Corporation (“Canopy Growth”) […] READ MORE: https://www.newcannabisventures.com/constellation-brands-injects-c245-million-into-canopy-growth-by-exercising-expiring-warrants/